Endocrinology, Vol 134, 1031-1038, Copyright © 1994 by Endocrine Society

ARTICLES

Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats

M Machwate, E Zerath, X Holy, P Pastoureau and PJ Marie
INSERM U-349, Paris, France.

We previously found that the inhibition of bone formation and trabecular osteopenia induced by skeletal unloading in rats are associated with reduced proliferation of osteoblastic cells lining the bone surface. In this study, we examined the effects of insulin-like growth factor-I (IGF-I) on trabecular bone formation, bone mineral density, and proliferation of marrow-derived osteoblastic cells in unloaded rats. Skeletal unloading of hind limbs was induced by tail suspension, and recombinant human IGF-I was administered at two different doses (1.3 or 2.0 mg/kg.day) in control and unloaded rats by continuous infusion for 14 days. Treatment with IGF-I had no effect on plasma glucose levels, body weight, or longitudinal bone growth. The double calcein-labeled surface, bone formation rate, and trabecular number measured at the tibial metaphysis were lower in unloaded rats compared to controls and were increased after IGF-I treatment. The increased number of bone-forming sites induced by IGF-I was associated with partial prevention of trabecular bone loss in unloaded rats. In contrast to the beneficial effects of IGF-I on bone formation and bone mineral content in unloaded rats, IGF-I had no effect in control rats. To evaluate the cellular mechanisms of action of IGF-I, marrow stromal cells were derived from the tibia of unloaded and control rats and studied in vitro. Unloading was associated with a decreased proliferation of alkaline phosphatase-positive (ALP+) marrow stromal cells. Treatment with IGF-I increased the number of ALP+ cells in unloaded rats, but not in control rats. IGF-I treatment increased ALP activity and osteocalcin production by marrow-derived cells in suspended and control rats, suggesting that IGF-I stimulated the proliferation and differentiation of osteoblast precursor cells. These results indicate that IGF-I infusion enhanced the recruitment of osteoblastic cells, increased trabecular bone formation, and partially prevented trabecular bone loss in unloaded rats, which supports the hypothesis that IGF-I may mediate in part the effects of loading on bone formation.

This article has been cited by other articles:

				M. Kolanczyk, N. Kossler, J. Kuhnisch, L. Lavitas, S. Stricker, U. Wilkening, I. Manjubala, P. Fratzl, R. Sporle, B. G. Herrmann, et al. Multiple roles for neurofibromin in skeletal development and growth Hum. Mol. Genet., April 15, 2007; 16(8): 874 - 886. [Abstract] [Full Text] [PDF]

				G. Radetti, G. D'Addato, D. Gatti, M. Bozzola, and S. Adami Influence of two different GH dosage regimens on final height, bone geometry and bone strength in GH-deficient children. Eur. J. Endocrinol., March 1, 2006; 154(3): 479 - 482. [Abstract] [Full Text] [PDF]

				L. Gilbert, X. He, P. Farmer, S. Boden, M. Kozlowski, J. Rubin, and M. S. Nanes Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-{alpha} Endocrinology, November 1, 2000; 141(11): 3956 - 3964. [Abstract] [Full Text] [PDF]

				N. Miyakoshi, C. Richman, X. Qin, D. J. Baylink, and S. Mohan Effects of Recombinant Insulin-Like Growth Factor-Binding Protein-4 on Bone Formation Parameters in Mice Endocrinology, December 1, 1999; 140(12): 5719 - 5728. [Abstract] [Full Text]

				C. Libanati, D. J. Baylink, E. Lois-Wenzel, N. Srinivasan, and S. Mohan Studies on the Potential Mediators of Skeletal Changes Occurring during Puberty in Girls J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2807 - 2814. [Abstract] [Full Text]

				O. Barou, S. Palle, L. Vico, C. Alexandre, and M.-H. Lafage-Proust Hindlimb unloading in rat decreases preosteoblast proliferation assessed in vivo with BrdU incorporation Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E108 - E114. [Abstract] [Full Text] [PDF]